Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies

Antisense oligonucleotides targeting SCN2A for the treatment of SCN1A encephalopathies

US Patent 11939582 · Granted Mar 26, 2024

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dynamic clamps and methods of use thereof2025
Compositions and methods for increasing expression of SCN2A2023
Proteinaceous molecules and methods of use2021
Treatment of obesity and related disorders2014
Diagnostic method for epilepsy2012
Methods for the diagnosis and treatment of epilepsy2010